Amphastar Pharmaceuticals
AMPH
59 hedge funds and large institutions have $158M invested in Amphastar Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 10 reducing their positions, and 8 closing their positions.
180% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 10
72% more capital invested
Capital invested by funds: $92.1M → $158M (+$66M)
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
7% more funds holding
Funds holding: 55 → 59 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$17.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.31M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$7.26M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$4.15M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$3.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$11.1M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.32M |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$1.94M |
| 4 |
FCE
Fiera Capital (Europe)
Grand Cayman,
Cayman Islands
|
-$1.51M |
| 5 |
JP Morgan Chase
New York
|
-$1.06M |
AMPH Hedge Fund Activity: Q1 2015 in Review
59 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q1 2015, worth a combined $158M — up 72% from $92.1M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new AMPH positions and 8 closed out — a net gain of 4 holders — while 28 added to existing stakes and 10 trimmed.
The largest buyer was Federated Hermes, adding an estimated $17.8M. The largest seller was Deerfield Management, cutting an estimated $11.1M.
- 59 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q1 2015, up from 55 in Q4 2014.
- Funds reported $158M of Amphastar Pharmaceuticals stock for Q1 2015, up 72% quarter-over-quarter.
- 12 funds opened new Amphastar Pharmaceuticals positions in Q1 2015 and 8 closed out, a net change of +4 holders.
- The largest Amphastar Pharmaceuticals buyer in Q1 2015 was Federated Hermes, an estimated $17.8M added.
- The largest Amphastar Pharmaceuticals seller in Q1 2015 was Deerfield Management, an estimated $11.1M sold.
Based on aggregated 13F filings for Q1 2015.